8-K
Current Report
Shuttle Pharmaceuticals Holdings, Inc. Filed Acc 0001493152-25-024618
Material agreement · Agreement ended · Exit or restructuring costs
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading form8-k.htm…